Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis

Pediatr Pulmonol. 1998 Nov;26(5):365-9. doi: 10.1002/(sici)1099-0496(199811)26:5<365::aid-ppul11>3.0.co;2-4.
No abstract available

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Child
  • Cryptogenic Organizing Pneumonia / diagnosis
  • Cryptogenic Organizing Pneumonia / drug therapy
  • Cyclophosphamide / administration & dosage
  • Disease Progression
  • Drug Therapy, Combination
  • Female
  • Hepatitis, Viral, Human / diagnosis*
  • Hepatitis, Viral, Human / drug therapy
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Lung Diseases, Interstitial / diagnosis*
  • Lung Diseases, Interstitial / drug therapy
  • Myositis / diagnosis*
  • Myositis / drug therapy
  • Parvoviridae Infections / diagnosis*
  • Parvoviridae Infections / drug therapy
  • Parvovirus B19, Human*

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide